Article Details

Vigil Neuroscience Inc: Promising Drug Development and Potential for Accelerated FDA ...

Retrieved on: 2024-07-19 18:18:27

Tags for this article:

Click the tags to see associated articles and topics

Vigil Neuroscience Inc: Promising Drug Development and Potential for Accelerated FDA .... View article details on hiswai:

Excerpt

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vigil Neuroscience Inc (VIGL – Research Report), reducing the price targ...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo